OpenAlex
PricingAboutJobs
Log inGet started
Work

A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity

HTML

Year: 2008
Type: article
Source: Cancer Research
DOI: 10.1158/0008-5472.can-07-0669
Authors: Joseph R. Garlich, Pradip De, Nandini Dey, Jing Dong Su, Xiaodong Peng, Antoinette Miller, Ravoori Murali, Yiling Lu, Gordon B. Mills, Vikas Kundra, H-K. Shu, Qiong Peng, Donald L. Durden
Institutions: Aflac (United States), Children's Healthcare of Atlanta, The University of Texas MD Anderson Cancer Center, Emory University
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: LY294002, prodrugs, pan-PI3K inhibitor, integrin targeting, tumor angiogenesis, anticancer activity, Akt phosphorylation, PTEN, tumor vasculature targeting, pharmacokinetics, U87 glioma
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: G1016969413, Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation, The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
OpenAlex ID: W2005448885
FWCI: 11.26
Cites: 38
Cited by: 292
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security